 PURPOSE: This phase II trial is studying the side effects of giving combination chemotherapy together with total-body irradiation followed by interleukin-2 IL-2, aldesleukin, and umbilical cord blood transplant and to see how well it works in treating patients with relapsed or refractory acute myeloid leukemia. 